Covered recipient · General Payments record
KAREN A OSTROWSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,396.17
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.62 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.96 | 7 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $53.88 | 2 |
| Amgen Inc. | $52.56 | 2 |
| Lilly USA, LLC | $49.85 | 2 |
| Incyte Corporation | $28.13 | 1 |
| Arcutis Biotherapeutics, Inc. | $23.11 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.82 | 1 |
| LEO Pharma Inc. | $16.03 | 1 |
| Almirall LLC | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.84 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772008 | CMS |
| ABBVIE INC. | $28.50 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772010 | CMS |
| ABBVIE INC. | $23.60 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772012 | CMS |
| ABBVIE INC. | $11.62 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772014 | CMS |
| ABBVIE INC. | $19.63 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772016 | CMS |
| ABBVIE INC. | $33.36 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772018 | CMS |
| ABBVIE INC. | $18.41 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107772020 | CMS |
| Almirall LLC | $14.28 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120643319 | CMS |
| Amgen Inc. | $30.62 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117646673 | CMS |
| Amgen Inc. | $21.94 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117646675 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.11 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121103412 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.82 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101506001 | CMS |
| Incyte Corporation | $28.13 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141297684 | CMS |
| LEO Pharma Inc. | $16.03 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152682325 | CMS |
| Lilly USA, LLC | $24.76 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135722103 | CMS |
| Lilly USA, LLC | $25.09 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135732812 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.76 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152243837 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $32.12 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152243835 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.